Company intelligence / Profile preview

Yair Capital Issuing

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Yair Capital Issuing is a financial entity primarily involved in the issuance of debt securities and investment management. While the name may appear in contexts related to capital raising for various sectors, it is not a biotechnology or life sciences company itself. Instead, it functions as a special purpose vehicle or financial intermediary for Yair Capital, an investment firm. Its activities are focused on structured finance and capital markets rather than drug development or healthcare services.

Industry: Investors

Beyond the preview

Go deeper on Yair Capital Issuing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yair Capital Issuing.

Explore the full profile